Hickey Benjamin

CIK 00017530555 companiesPRINCETON, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001753055

Recent Transactions

50 trades

Disposition to Issuer
Mural Oncology plc
Stock Option (right to buy)
2025-12-05−8,462→ 0 total
Disposition to Issuer
Mural Oncology plc
Stock Option (right to buy)
2025-12-05−15,021→ 0 total
Disposition to Issuer
Mural Oncology plc
Stock Option (right to buy)
2025-12-05−8,637→ 0 total
Award
Mural Oncology plc
Stock Option (right to buy)
2025-06-11+8,637→ 8,637 total
Sale
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2025-05-09$38.01/sh−97.391→ 0 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Performance Shares
2025-03-10+20,084→ 20,084 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Market Share Units
2025-03-10+13,389→ 13,389 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2025-03-01$59.62/sh−1,630→ 8,789 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2025-03-01−3,286→ 6,572 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2025-03-01+3,286→ 10,419 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2025-02-01+10,078→ 10,858 total
Exercise/Conversion
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2025-02-01−10,078→ 20,158 total
Tax Payment
BRISTOL MYERS SQUIBB CO$BMY
Common Stock, $0.10 par value
2025-02-01$58.95/sh−3,725→ 7,133 total
Award
Mural Oncology plc
Stock Option (right to buy)
2024-05-30+8,462→ 8,462 total
Award
Mural Oncology plc
Stock Option (right to buy)
2024-05-30$3.35/sh+8,462→ 8,462 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Performance Shares
2024-03-10+5,805→ 5,805 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Market Share Units
2024-03-10+3,870→ 3,870 total
Award
BRISTOL MYERS SQUIBB CO$BMY
Restricted Stock Units
2024-03-01+9,858→ 9,858 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−72,206→ 17,021 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Option to Purchase Common Stock
2024-01-23−2,128→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Option to Purchase Common Stock
2024-01-23−43,328→ 0 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−27,801→ 89,227 total
Disposition to Issuer
Mirati Therapeutics, Inc.
Common Stock
2024-01-23−17,021→ 0 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2024-01-16$59.02/sh−631→ 117,028 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2024-01-16$59.02/sh−966→ 117,659 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2024-01-08$58.92/sh−2,090→ 118,625 total
Award
Mirati Therapeutics, Inc.
Common Stock
2023-12-29$58.75/sh+17,021→ 120,715 total
Award
Mural Oncology plc
Stock Option (right to buy)
2023-12-14+15,021→ 15,021 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2023-12-13$56.67/sh−2,220→ 103,694 total
Award
Mirati Therapeutics, Inc.
Common Stock
2023-08-09$37.00/sh+22,297→ 105,914 total
Award
Mirati Therapeutics, Inc.
Common Stock
2023-01-20+36,394→ 83,617 total
Award
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2023-01-20+45,456→ 45,456 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2023-01-17$42.38/sh−947→ 47,842 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2023-01-17$42.38/sh−619→ 47,223 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2023-01-09$45.37/sh−2,088→ 48,789 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2022-12-21$40.41/sh−3,248→ 50,877 total
Award
Mirati Therapeutics, Inc.
Common Stock
2022-12-19+19,149→ 54,125 total
Award
Surface Oncology, Inc.
Stock Option (Right to Buy)
2022-06-08+24,000→ 24,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2022-01-18$120.48/sh−627→ 34,976 total
Award
Mirati Therapeutics, Inc.
Common Stock
2022-01-14+10,755→ 35,603 total
Award
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2022-01-14+17,821→ 17,821 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2022-01-07$135.94/sh−1,964→ 24,848 total
Award
Surface Oncology, Inc.
Stock Option (Right to Buy)
2022-01-03+24,000→ 24,000 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-19$175.54/sh−588→ 28,593 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Non Qualified Stock Option (right to buy)
2021-03-19−2,369→ 30,116 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-19$176.42/sh−1,350→ 27,243 total
Exercise/Conversion
Mirati Therapeutics, Inc.
Common Stock
2021-03-19$114.33/sh+2,369→ 29,181 total
Sale
Mirati Therapeutics, Inc.
Common Stock
2021-03-19$177.71/sh−431→ 26,812 total
Award
Mirati Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-01-15+10,979→ 10,979 total
Award
Mirati Therapeutics, Inc.
Common Stock
2021-01-15+7,023→ 26,812 total

Companies

Recent Filings

Address

BRISTOL-MYERS SQUIBB COMPANY ROUTE 206 AND PROVINCE LINE ROAD

PRINCETON, NJ, 08543

View on SEC.gov